1h Free Analyst Time
The publisher's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma - Drugs In Development, 2022, provides an overview of the Melanoma (Oncology) pipeline landscape.Speak directly to the analyst to clarify any post sales queries you may have.
Melanoma is a tumor that develops as a result of the malignant transformation of melanocytes. These cells are derived from the neural crest. Melanomas usually occur on the skin but can arise in other locations where neural crest cells migrate, such as in the gastrointestinal tract or brain. It is more common in women than in men. In women, the most common site is the legs and melanomas in men are most common on the back. Unusual moles, sores, lumps, blemishes, markings, or changes in the way an area of the skin looks or feels are sign of melanoma. Treatment includes surgery, radiation and proton therapy.
Report Highlights
The publisher's Pharmaceutical and Healthcare latest pipeline guide Melanoma - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Melanoma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Melanoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Melanoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 1, 25, 252, 242, 6, 29, 349, 49 and 5 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Phase 0, Preclinical and Discovery stages comprises 3, 21, 18, 1, 86 and 14 molecules, respectively.
Melanoma (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Melanoma (Oncology).
- The pipeline guide reviews pipeline therapeutics for Melanoma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Melanoma (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Melanoma (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Melanoma (Oncology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Melanoma (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Melanoma (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
- Introduction
- Report Coverage
- Melanoma - Overview
- Melanoma - Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Pipeline by Universities/Institutes
- Products under Development by Companies
- Products under Development by Universities/Institutes
- Melanoma - Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
- Melanoma - Companies Involved in Therapeutics Development
- Melanoma - Drug Profiles
- Melanoma - Dormant Projects
- Melanoma - Discontinued Products
- Melanoma - Product Development Milestones
- Featured News & Press Releases
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact Us
- Disclaimer
- Number of Products under Development for Melanoma, 2022
- Number of Products under Development by Companies, 2022
- Number of Products under Development by Universities/Institutes, 2022
- Products under Development by Companies, 2022
- Products under Development by Universities/Institutes, 2022
- Number of Products by Stage and Target, 2022
- Number of Products by Stage and Mechanism of Action, 2022
- Number of Products by Stage and Route of Administration, 2022
- Number of Products by Stage and Molecule Type, 2022
- Melanoma - Dormant Projects, 2022
- Melanoma - Discontinued Products, 2022
- Number of Products under Development for Melanoma, 2022
- Number of Products under Development by Companies, 2022
- Number of Products under Development by Universities/Institutes, 2022
- Number of Products by Top 10 Targets, 2022
- Number of Products by Stage and Top 10 Targets, 2022
- Number of Products by Top 10 Mechanism of Actions, 2022
- Number of Products by Stage and Top 10 Mechanism of Actions, 2022
- Number of Products by Top 10 Routes of Administration, 2022
- Number of Products by Stage and Top 10 Routes of Administration, 2022
- Number of Products by Top 10 Molecule Types, 2022
- Number of Products by Stage and Top 10 Molecule Types, 2022
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 4D Pharma Plc
- 4SC AG
- 7 Hills Pharma LLC
- 9 Meters Biopharma Inc
- Aadi Bioscience Inc
- Abbisko Cayman Limited
- AbbVie Inc
- Abcuro Inc
- Abion Inc
- Abivax SA
- ABM Therapeutics Inc
- AC Bioscience SA
- Accendatech Co Ltd
- Accuitis Pharmaceuticals Inc
- Acepodia Inc
- Achilles Therapeutics Plc
- Actuate Therapeutics Inc
- Actym Therapeutics Inc
- Adagene Suzhou Ltd
- Adaptimmune Therapeutics Plc
- Adare Pharma Solutions
- ADC Therapeutics SA
- Adlai Nortye Biopharma Co Ltd
- Advanced BioDesign
- AdvanCell Isotopes Pty Ltd
- Advenchen Laboratories LLC
- Adze Biotechnology Inc
- Aeglea BioTherapeutics Inc
- Affichem SA
- Agenus Inc
- AI Therapeutics Inc
- AIkido Pharma Inc
- AIM ImmunoTech Inc
- AIMM Therapeutics BV (Inactive)
- AiVita Biomedical Inc
- Akeso Inc
- Alkermes Plc
- Allergy Therapeutics Plc
- Alligator Bioscience AB
- AlphaMab Co Ltd
- Alphamab Oncology
- AlphaVax Inc
- Alpine Immune Sciences Inc
- ALS Biopharma LLC
- Alyra Therapeutics Inc
- Ambrx Biopharma Inc
- Amgen Inc
- Aminex Therapeutics Inc
- Amitech Therapeutic Solutions Inc
- Anaveon AG
- Andes Biotechnologies
- AnGes Inc
- Anhorn Medicines Co Ltd
- Ansun Biopharma Inc
- AntiCancer Inc
- APEIRON Biologics AG
- Apexian Pharmaceuticals Inc
- Apexigen Inc
- Aphios Corp
- APO-T BV
- Apogenix AG
- Apollomics Inc
- Arcus Biosciences Inc
- Ardan Pharma
- Arovella Therapeutics Ltd
- Ascendis Pharma AS
- Ascentage Pharma Group International
- Asher Biotherapeutics Inc
- Astellas Pharma Inc
- Astex Pharmaceuticals Inc
- AstraZeneca Plc
- Athenex Inc
- Atreca Inc
- aTyr Pharma Inc
- Aulos Bioscience Inc
- Aurigene Discovery Technologies Ltd
- Autolus Therapeutics Plc
- Avalia Immunotherapies Ltd
- Avidin Biotechnology Ltd
- Avotres Inc
- Avstera Therapeutics Inc
- Axter Therapeutics Ltd
- B-Side Pharma Ltd
- Bantam Pharmaceutical LLC
- Barricade Therapeutics Corp
- Bayer AG
- BeiGene Ltd
- Beijing Immunochina Pharmaceuticals Co Ltd
- Beijing Mabworks Biotech Co Ltd
- Beijing Neoantigen Biotechnology Co Ltd
- Beijing Tricision Biotherapeutics Inc
- Beijing Weiyuan Likang Biological Technology Co Ltd
- BerGenBio ASA
- Bessor Pharma LLC
- Betta Pharmaceuticals Co Ltd
- BeyondSpring Inc
- Binjiang Pharma, Inc.
- Bio-Cancer Treatment International Ltd
- Bio-Thera Solutions Ltd
- BioAtla Inc
- Biocad
- Biocytogen Pharmaceuticals (Beijing) Co Ltd
- Biogazelle NV
- Biohaven Pharmaceutical Holding Company Ltd
- BioInvent International AB
- BioLineRx Ltd
- BioMed Valley Discoveries Inc
- Biomica
- BioNTech SE
- Bioquark Inc
- Biosion Inc
- BioVaxys Technology Corp
- Biovista Inc
- Bioviz Technologies Pvt Ltd
- BioXcel Therapeutics Inc
- bioXXmed AG
- BJ Bioscience Inc
- Blueprint Medicines Corp
- Boehringer Ingelheim International GmbH
- Boston Pharmaceuticals Inc
- Brenus Pharma SA
- BriaCell Therapeutics Corp
- BridgeBio Pharma Inc
- Bristol-Myers Squibb Co
- Bromodomain Pharmaceuticals Inc
- Byondis BV
- C4 Therapeutics Inc
- Calidi Biotherapeutics Inc
- Calithera Biosciences Inc
- Can-Fite BioPharma Ltd
- Cancure Ltd
- Cantargia AB
- Canthera Discovery
- CanWell Pharma Inc
- Catalym GmbH
- CDR-Life Inc
- Celdara Medical LLC
- Celldex Therapeutics Inc
- Cellestia Biotech AG
- Cellid Co Ltd
- Celprogen Inc
- Centrymed Pharmaceutical Inc
- Centurion BioPharma Corp
- Checkpoint Therapeutics Inc
- Chengdu Fanxi Biopharma Co Ltd
- Chia Tai Tianqing Pharmaceutical Group Co Ltd
- Chimeric Therapeutics Ltd
- Chimerix Inc
- Chineo Med Beijing Co Ltd
- Chinook Therapeutics Inc
- Chugai Pharmaceutical Co Ltd
- Claradele Pharmaceuticals Inc
- Cloaked Therapeutics LLC
- CNBX Pharmaceuticals Inc
- Codagenix Inc
- Codiak BioSciences Inc
- CohBar Inc
- Compass Therapeutics Inc
- Convalife
- Corvus Pharmaceuticals Inc
- CStone Pharmaceuticals Co Ltd
- Cue Biopharma Inc
- Cura Therapeutics LLC
- Curebiotech Inc
- CureLab Oncology Inc
- Curevac NV
- Curigin Co Ltd
- Cynata Therapeutics Ltd
- Cytodyn Inc
- Cytovation AS
- CyTuVax BV
- CZ BioMed Corp
- Daiichi Sankyo Co Ltd
- Debiopharm International SA
- Deciphera Pharmaceuticals Inc
- Defence Therapeutics Inc
- DEKK-TEC Inc
- Delta TpX Inc
- Delta-Fly Pharma Inc
- Dicerna Pharmaceuticals Inc
- DNAtrix Inc
- Dracen Pharmaceuticals Inc
- Duet Therapeutics Inc
- Dyadic International Inc
- Eden Biologics Inc
- Eikonoklastes Therapeutics Inc
- Eisai Co Ltd
- Eli Lilly and Co
- Elicera Therapeutics AB
- Elicio Therapeutics Inc
- Ella Therapeutics Ltd
- Elpiscience Biopharma Ltd
- Emcure Pharmaceuticals Ltd
- Enara Bio Ltd
- ENB Therapeutics LLC
- Epigene Therapeutics Inc
- EpimAb Biotherapeutics Inc
- Epizyme Inc
- Erasca Inc
- Eternity Bioscience Inc
- Eucure (Beijing) Biopharma Co Ltd
- Eutilex Co Ltd
- Evaxion Biotech ApS
- Evotec SE
- Exelixis Inc
- F-star Therapeutics Inc
- F. Hoffmann-La Roche Ltd
- Faknostics LLC
- Faron Pharmaceuticals Oy
- Fate Therapeutics Inc
- Flow Pharma Inc
- Fochon Pharmaceutical Ltd
- Forte Biosciences Inc
- Fujian Haixi New Medicine Creation Co Ltd
- Galderma SA
- Galectin Therapeutics Inc
- Galecto Inc
- Gene Surgery
- Genelux Corp
- Genemedicine Ltd
- Genentech USA Inc
- Generium
- Genexine Inc
- Gennao Bio Inc
- Genocea Biosciences Inc
- GenoImmune Therapeutics Biotechnology Co Ltd
- GigaGen Inc
- Gilead Sciences Inc
- GLG Pharma SA
- GlycoNex Inc
- Gmax Biopharm LLC
- GNT Biotech and Medicals Corp
- Gnubiotics Sciences SA
- GO Therapeutics Inc
- Gradalis Inc
- GSK plc
- Guangdong Zhongsheng Pharmaceutical Co Ltd
- Guangzhou FineImmune Biotechnology Co Ltd
- Guangzhou Sinogen Pharmaceutical Co Ltd
- Guangzhou Yinming Biomedical Technology Co Ltd
- HaimBio Ltd
- Hangzhou Neoantigen Therapeutics Co Ltd
- Hangzhou Zenshine Pharmaceuticals Co Ltd
- Hanmi Pharmaceuticals Co Ltd
- Harbin Gloria Pharmaceuticals Co Ltd
- Harbour BioMed (Guangzhou) Co Ltd
- HCW Biologics Inc
- Hercules Pharmaceuticals BV
- Hibercell Inc
- HiFiBiO Therapeutics Inc
- Highlight Therapeutics SL
- HKND YB1 Pharmaceutical Ltd
- Hookipa Pharma Inc
- Horizon Therapeutics Plc
- Huabo Biopharm (Shanghai) Co Ltd
- Huahui Anjian (Beijing) Biotechnology Co Ltd
- Hualan Biological Engineering Inc
- Hummingbird Bioscience Pte Ltd
- HylaPharm
- I-Mab
- Ideaya Biosciences Inc
- ImCheck Therapeutics SAS
- Immatics NV
- IMMD Inc
- Immodulon Therapeutics Ltd
- Immune Modulatory Therapies LLC
- ImmuneCyte Inc
- Immuneering Corp
- ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
- ImmuneSensor Therapeutics Inc
- Immunetune BV
- ImmuNext Inc
- ImmunityBio Inc
- Immunocore Holdings Plc
- Immunome Inc
- Immunophotonics Inc
- Immunos Therapeutics AG
- ImmunSYS Inc
- Immutep Ltd
- Immvira Co Ltd
- Imugene Ltd
- Incuron
- Incyte Corp
- Infinity Pharmaceuticals Inc
- Ingenew Pharmaceuticals Inc
- IngenoVax LLC
- Inhibrx Inc
- Inmune Bio Inc
- Innate Pharma SA
- InnoBioPharma LLC
- Innovative Cellular Therapeutics Co Ltd
- Innovent Biologics Inc
- Innovimmune Biotherapeutics Inc
- Inovio Pharmaceuticals Inc
- Instil Bio Inc
- IntelliStem Technologies Inc
- Intensity Therapeutics Inc
- InterK Peptide Therapeutics Ltd
- InteRNA Technologies BV
- InxMed (Beijing) Co Ltd
- IO Biotech Inc
- iOnctura SA
- Iovance Biotherapeutics Inc
- ISOThrive Inc
- Istari Oncology Inc
- ISU ABXIS Co Ltd
- iTeos Therapeutics Inc
- Jacobio Pharmaceuticals Group Co Ltd
- Jiangsu Chia-tai Tianqing Pharmaceutical Co Ltd
- Jiangsu Hengrui Medicine Co Ltd
- Jiangsu Sinorda Biomedicine Co Ltd
- Jina Pharmaceuticals Inc
- Johnson & Johnson
- Joint Biosciences Ltd
- Jounce Therapeutics Inc
- JS InnoPharm (Shanghai) Ltd
- JSK Therapeutics Inc
- JSR Life Sciences LLC
- Jubilant Therapeutics Inc
- Kadmon Holdings Inc
- Kairos Pharma Ltd
- Kartos Therapeutics Inc
- Karus Therapeutics Ltd
- Karyopharm Therapeutics Inc
- Kazia Therapeutics Ltd
- Kezar Life Sciences Inc
- Kine Sciences
- Kinnate Biopharma Inc
- Kolon Life Science Inc
- Komipharm International Co Ltd
- Kringle Pharma Inc
- KSQ Therapeutics Inc
- Kymab Ltd
- Laboratorio Pablo Cassara SRL
- Latima SIA
- Learmont Pharmaceuticals Inc
- Leidos Health Holdings LLC
- Lentigen Technology Inc
- Lepu Biopharma Co Ltd
- Lidds AB
- Ligand Pharmaceuticals Inc
- LintonPharm Co Ltd
- Lipo-Immuno Tech LLC
- Lixte Biotechnology Holdings Inc
- Lokon Pharma AB
- Luye Pharma Group Ltd
- Lyell Immunopharma Inc
- Lytix Biopharma AS
- Lyvgen Biopharma Ltd
- MaaT Pharma
- Mabwell Shanghai Bioscience Co Ltd
- MacroGenics Inc
- MAIA Biotechnology Inc
- MaxiVAX SA
- MedGene Therapeutics Inc
- MediaPharma SRL
- Medicenna Therapeutics Corp
- MediciNova Inc
- MediGene AG
- Mediolanum farmaceutici SpA
- MedPacto Inc
- Mekanistic Therapeutics LLC
- Memgen Inc
- Merck & Co Inc
- Merck KGaA
- Merus NV
- Meryx Inc
- METiS Therapeutics Inc
- MGC Pharmaceuticals Ltd
- Microbiotica Ltd
- Millennium Pharmaceuticals Inc
- Miltenyi Biomedicine GmbH
- Mina Therapeutics Ltd
- MiNK Therapeutics Inc
- Mirati Therapeutics Inc
- MiReven Pty Ltd
- Moderna Inc
- Molecular Partners AG
- Molecular Templates Inc
- Moleculin Biotech Inc
- Molecure SA
- Morphiex Biotherapeutics Inc
- Morphogenesis Inc
- Mosaic ImmunoEngineering Inc
- Mountain Valley MD Holdings Inc
- Multitude therapeutics Inc
- MultiVir Inc
- MyeloRx LLC
- NA Vaccine Research Institute Co Ltd
- Nanjing Aimeifei Biomedical Technology Co Ltd
- Nanobiotix SA
- NantBioScience Inc
- Neonc Technologies Inc
- NeoTX Therapeutics Ltd
- NeuClone Pty Ltd
- Neumedicines Inc
- New Amsterdam Sciences Inc
- NewG Lab Pharma Co Ltd
- NewG Lab Pharma Inc
- NEX-I Inc
- NextCure Inc
- NGM Biopharmaceuticals Inc
- NH TherAguix SAS
- NightHawk Biosciences Inc
- Nimbus Therapeutics LLC
- Ningbo Wenda Pharmaceutical Technology Co Ltd
- NirogyOne Therapeutics Inc
- Nouscom AG
- Novartis AG
- Nubiyota LLC
- NuCana Plc
- Nurix Therapeutics Inc
- Nuvation Bio Inc
- Nuvectis Pharma Inc
- Nynex Therapeutics LLC
- Obsidian Therapeutics Inc
- Ocuphire Pharma Inc
- Olatec Therapeutics LLC
- OliPass Corporation
- Omeros Corp
- Ona Therapeutics SL
- OncoC4 Inc
- Oncology Research International Ltd
- Oncolys BioPharma Inc
- Onconova Therapeutics Inc
- OncoResponse Inc
- Oncorus Inc
- OncoSec Medical Inc
- OncoTartis Inc
- Oncotelic Therapeutics Inc
- Oncovir Inc
- Oneness Biotech Co Ltd
- OnKure Inc
- Ono Pharmaceutical Co Ltd
- Orano Med LLC
- Orbis Health Solutions LLC
- Orgenesis Inc
- Orpheus Therapeutics Inc
- Oryn Therapeutics
- Otsuka Pharmaceutical Co Ltd
- Oxcia AB
- Oxford BioTherapeutics Ltd
- Pacific Northwest Biotechnology LLC
- Pact Pharma Inc
- Palleon Pharmaceuticals Inc
- Palm Therapeutics Inc
- Pan Cancer T BV
- Paranta Biosciences Ltd
- Partner Therapeutics Inc
- PCI Biotech Holding ASA
- PDC Line Pharma SAS
- PDS Biotechnology Corp
- PepVax Inc
- PersonGen BioTherapeutics (Suzhou) Co Ltd
- Pfizer Inc
- PharmaTher Holdings Ltd
- Philogen SpA
- Phio Pharmaceuticals Corp
- Phoenix Life Sciences International Ltd
- Phoenix Molecular Designs
- PHusis Therapeutics Inc
- PlantForm Corp
- Plexxikon Inc
- Plus Therapeutics Inc
- POINT Biopharma Global Inc
- PokeAcell
- Polynoma LLC
- Polyplus-Transfection SA
- Portage Biotech Inc
- Prelude Therapeutics Inc
- Prestige BioPharma Ltd
- Primevax Immuno Oncology Inc
- PRISM Pharma Co Ltd
- Processa Pharmaceuticals Inc
- Promore Pharma AB
- Propanc Biopharma Inc
- Protheragen Inc
- Provectus Biopharmaceuticals Inc
- Puma Biotechnology Inc
- Puretech Health Plc
- Purple Biotech Ltd
- PYC Therapeutics Ltd
- QBiotics Group Ltd
- Qilu Pharmaceutical Co Ltd
- Qilu Puget Sound Biotherapeutics Corp
- Qu Biologics Inc
- Quadriga BioSciences Inc
- R-Pharm
- Race Oncology Ltd
- Ranger Biotechnologies AS
- Rapa Therapeutics LLC
- Recombio SL
- Regeneron Pharmaceuticals Inc
- RemeGen Co Ltd
- Repertoire Immune Medicines Inc
- Replimune Ltd
- Resonant Therapeutics Inc
- RetroVirox Inc
- Reven Holdings Inc
- Revere Pharmaceuticals Inc
- Rubicon Biotechnology Inc
- Salarius Pharmaceuticals Inc
- Salubris Biotherapeutics Inc
- SANOCHEMIA Pharmazeutika GmbH
- Sanofi
- Sapience Therapeutics Inc
- Sapphire Biotech Inc
- Sareum Holdings Plc
- Scancell Holdings Plc
- Scholar Rock Inc
- Seagen Inc
- Secura Bio Inc
- Seven and Eight Biopharmaceuticals Corp
- Seven and Eight Biopharmaceuticals Inc
- Shandong Taize Huikang Biomedical Co Ltd
- Shandong Xinchuang Biological Technology Co Ltd
- Shanghai Celgen Bio-Pharmaceutical Co Ltd
- Shanghai De Novo Pharmatech Co Ltd
- Shanghai Gencells Therapeutics Co Ltd
- Shanghai Grit Biotechnology Inc
- Shanghai Haihe Biopharma Co Ltd
- Shanghai Henlius Biotech Inc
- Shanghai Hycharm Inc
- Shanghai Junshi Bioscience Co Ltd
- Shanghai Yuansong Biotechnology Co Ltd
- Shattuck Labs Inc
- Shenogen Pharma Group Ltd
- Shenzhen Chipscreen Biosciences Co Ltd
- Shionogi & Co Ltd
- Sichuan Huiyang Life Science and Technology Corp
- Sillajen Biotherapeutics
- Simcha Therapeutics Inc
- Sino Biopharmaceutical Ltd
- Sirnaomics Ltd
- Sonnet BioTherapeutics Holdings Inc
- Sonoval LLC
- Sorrento Therapeutics Inc
- SOTIO Biotech AS
- SpringWorks Therapeutics Inc
- Starwise Therapeutics LLC
- STAT3 Therapeutics Inc
- Statera Biopharma Inc
- Stcube Inc
- Stella Pharmaceuticals Pvt Ltd
- Sumitomo Dainippon Pharma Oncology, Inc
- Sumitomo Pharma Co Ltd
- Suntec Medical (Taiwan) Inc
- Susavion Biosciences Inc
- SuviCa Inc
- Suzhou BlueHorse Therapeutics Co Ltd
- Suzhou Dingfu Target Biotechnology Co Ltd
- Suzhou Everhealth Biomedical Co Ltd
- Suzhou Maximum Bio-tech Co Ltd
- Suzhou Neupharma Co Ltd
- SynDevRx Inc
- Syndivia SAS
- SynOx Therapeutics Ltd
- Synthekine Inc
- Synthis Therapeutics Inc
- Syntrix Pharmaceuticals
- Systimmune Inc
- T-Cure Bioscience Inc
- Tactical Therapeutics Inc
- Tactiva Therapeutics LLC
- TAE Life Sciences LLC
- Taiga Biotechnologies Inc
- Tailored Therapeutics LLC
- TaiRx Inc
- Takara Bio Inc
- Takeda Pharmaceutical Co Ltd
- Takis Srl
- Targazyme Inc
- Targovax ASA
- TCR Cure Biopharma Technology Co Ltd
- TCRx Therapeutics Co Ltd
- Telesis Therapeutics LLC
- Teon Therapeutics Inc
- Tetranov International Inc
- Tevogen Bio Inc
- Theratechnologies Inc
- Theravectys SA
- Tikcro Technologies Ltd
- TILT Biotherapeutics Ltd
- Timmune Biotech Inc
- Tollbridge Therapeutics LLC
- Toray Industries Inc
- Trained Therapeutix Discovery Inc
- Treadwell Therapeutics Inc
- TREAT U SA
- Treos Bio Ltd
- TScan Therapeutics Inc
- Turning Point Therapeutics Inc
- Turnstone Biologics Inc
- Tvardi Therapeutics Inc
- TVAX Biomedical Inc
- UBI Pharma Inc
- UbiVac Inc
- Ultimovacs AS
- United Immunity Co Ltd
- Vaccinex Inc
- Vaccizone
- Vacthera BioTech GmbH
- Valo Therapeutics Oy
- Vascular Biogenics Ltd
- Vault Pharma Inc
- Vaxess Technologies Inc
- Vaxil Bio Therapeutics Ltd
- Vaximm AG
- Veana Therapeutics LLC
- Vedanta Biosciences Inc
- Verastem Inc
- VerImmune Inc
- Verseau Therapeutics Inc
- Veru Inc
- Vichem Chemie Research Ltd
- Viewpoint Molecular Targeting LLC
- Vincerx Pharma Inc
- Virocure Inc
- ViruCure Therapeutics Ltd
- VM Discovery Inc
- VREX Therapeutics Inc
- Vyriad Inc
- Werewolf Therapeutics Inc
- Western Oncolytics Ltd (Inactive)
- WindMIL Therapeutics Inc
- WntResearch AB
- Wugen Inc
- Wuhan Binhui Biotechnology Co Ltd
- Wuhan YZY Biopharma Co Ltd
- X4 Pharmaceuticals Inc
- Xbrane Biopharma AB
- Xcovery Holding Co LLC
- XEME BioPharma Inc
- Xencor Inc
- Xiangxue Life Sciences
- Xilio Therapeutics Inc
- Xynomic Pharmaceuticals Holdings Inc
- Y-mAbs Therapeutics Inc
- Yisheng Biopharma Co Ltd
- Ymmunobio AG
- Yooyoung Pharm Co Ltd
- Yukin Therapeutics SAS
- Zelluna Immunotherapy AS
- Zenith Epigenetics Ltd
- Zhejiang Teruisi Pharmaceutical Co Ltd
- Zhejiang Yangshengtang Biotech Co Ltd
- Zucero Therapeutics Ltd
- Zylem Biosciences Inc
